The results showed that the OS time of the ANXA1 low expression group was significantly lower than that of the ANXA1 high expression group in primary (P<0.001) and metastatic ES patients (P=0.028), while there was no significant difference in recurrent ES patients (Supplementary Figure 1). The gene discussed is ANXA1; the disease is Ewing sarcoma.